)

Sai Life Sciences (SAILIFE) investor relations material
Sai Life Sciences Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Q1 FY26 began with strong momentum in discovery, development, and commercial manufacturing, reflecting deepening client relationships and operational excellence.
Strategic progress included expanding the integrated discovery platform, launching a new biology base at Hyderabad, and investing in new Biology Labs and Process R&D Block to nearly double R&D capacity.
Focused on scaling execution, strengthening client partnerships, and investing in technology and talent for sustained long-term value.
Board approved unaudited standalone and consolidated financial results for the quarter ended 30 June 2025.
250+ scientists and technicians were onboarded, and 11 client and regulatory audits were successfully completed, reinforcing quality and compliance.
Financial highlights
Q1 FY26 consolidated revenue reached INR 4,964.19 million (₹496 crores), up 77% year-over-year from INR 2,797.23 million (₹218 crores) in Q1 FY25.
CDMO business revenue grew 113% year-over-year to INR 3,160 million (₹316 crores), while CRO revenue increased 38% to INR 1,820 million (₹182 crores).
EBITDA rose 305% year-over-year to INR 1,250 million (₹125 crores), with margins expanding to 25%, a 14% improvement.
PAT turned positive at INR 605 million (₹60 crores), compared to a loss of INR 135 million in Q1 FY25.
Capital expenditure for the quarter was INR 1,340 million (₹134 crores), focused on capacity and capability expansion.
Outlook and guidance
Positioned for 15-20% revenue CAGR over 3-5 years and 28-30% EBITDA margins over the next 2-3 years.
Continued strong momentum is expected, with the CDMO business noted as lumpy and best viewed over the long term.
No one-off items impacted Q1 results; the trend of H2 outperforming H1 is expected to continue.
Strategic investments are set to double R&D capacity by next year and increase manufacturing capacity by 80% by FY27.
Management maintains a 3-5 year average revenue growth target of 15%.
Next Sai Life Sciences earnings date

Next Sai Life Sciences earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage